Oxford Lane Capital Corp.
Oxford Lane Capital Corp. (OXLCN) Financial Performance & Income Statement Overview
Review Oxford Lane Capital Corp. (OXLCN) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Oxford Lane Capital Corp. (OXLCN) Income Statement & Financial Overview
Explore comprehensive income reports for Oxford Lane Capital Corp. OXLCN, broken down by year and quarter.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $223.53M | $204.20M | $157.58M | $133.07M |
Cost of Revenue | $63.18M | $51.20M | $41.46M | $36.03M |
Gross Profit | $0.00 | $153.002M | $116.11M | $97.04M |
Gross Profit Ratio | $0.00 | $0.75 | $0.74 | $0.73 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $0.00 | $0.00 | -$20.18M | -$34.63M |
Total Costs & Expenses | -$219.87M | $120.94M | $136.29M | $131.67M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $16.43M | $16.43M |
Depreciation & Amortization | $0.00 | $0.00 | $119.86M | $115.25M |
EBITDA | $3.66M | $83.26M | $136.29M | $131.67M |
EBITDA Ratio | $0.02 | $0.41 | $0.86 | $0.99 |
Operating Income | $3.66M | $83.26M | $119.86M | $115.25M |
Operating Income Ratio | $0.02 | $0.41 | $0.76 | $0.87 |
Other Income/Expenses (Net) | -$20.79M | -$17.67M | -$16.43M | -$16.43M |
Income Before Tax | -$17.14M | $65.59M | $1.00 | $1.00 |
Income Before Tax Ratio | -$0.08 | $0.32 | $0.00 | $0.00 |
Income Tax Expense | $0.00 | $0.00 | $1.00 | $1.00 |
Net Income | -$17.14M | $65.59M | $217.93M | $202.18M |
Net Income Ratio | -$0.08 | $0.32 | $1.38 | $1.52 |
EPS | -$0.04 | $0.26 | $1.00 | $202.18M |
Diluted EPS | -$0.04 | $0.26 | $1.00 | -$16.43M |
Weighted Avg Shares Outstanding | $453.18M | $252.28M | $217.93M | $202.18M |
Weighted Avg Shares Outstanding (Diluted) | $453.18M | $252.28M | $217.93M | $202.18M |
The company's financials show resilient growth, with revenue advancing from $133.07M in Q2 2023 to $223.53M in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to 73% in Q2 2023. Operating income hit $3.66M last quarter, sustaining a consistent 2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.66M. Net income dropped to -$17.14M, while earnings per share reached -$0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan